Literature DB >> 31972425

The role of JAK/STAT signaling pathway and its inhibitors in diseases.

Ping Xin1, Xiaoyun Xu1, Chengjie Deng1, Shuang Liu1, Youzhi Wang2, Xuegang Zhou1, Hongxing Ma3, Donghua Wei1, Shiqin Sun4.   

Abstract

The JAK/STAT signaling pathway is an universally expressed intracellular signal transduction pathway and involved in many crucial biological processes, including cell proliferation, differentiation, apoptosis, and immune regulation. It provides a direct mechanism for extracellular factors-regulated gene expression. Current researches on this pathway have been focusing on the inflammatory and neoplastic diseases and related drug. The mechanism of JAK/STAT signaling is relatively simple. However, the biological consequences of the pathway are complicated due to its crosstalk with other signaling pathways. In addition, there is increasing evidence indicates that the persistent activation of JAK/STAT signaling pathway is closely related to many immune and inflammatory diseases, yet the specific mechanism remains unclear. Therefore, it is necessary to study the detailed mechanisms of JAK/STAT signaling in disease formation to provide critical reference for clinical treatments of the diseases. In this review, we focus on the structure of JAKs and STATs, the JAK/STAT signaling pathway and its negative regulators, the associated diseases, and the JAK inhibitors for the clinical therapy.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  JAK/STAT pathway and diseases; JAK/STAT signaling pathway; JAKs inhibitors and diseases; Negative regulators

Year:  2020        PMID: 31972425     DOI: 10.1016/j.intimp.2020.106210

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  89 in total

1.  Down-Regulation of ID2-AS1 Alleviates the Neuronal Injury Induced by 1-Methy1-4-Phenylpyridinium in Human Neuroblastoma Cell Line SH-SY5Y Cells Through Regulating miR-199a-5p/IFNAR1/JAK2/STAT1 Axis.

Authors:  Furong Xu; Hui Wang; Ju Tian; Haiyan Xu
Journal:  Neurochem Res       Date:  2021-05-29       Impact factor: 3.996

Review 2.  [Recent research on tofacitinib in the treatment of pediatric rheumatic diseases].

Authors:  Shi-Hai Zhou; Ya-Qun Xiong; Ya Chen
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-04-15

3.  Microrna-1224-5p Is a Potential Prognostic and Therapeutic Biomarker in Glioblastoma: Integrating Bioinformatics and Clinical Analyses.

Authors:  Xing Wei; Qing-Mei Zhang; Chang Liu; Song Wu; Wei-Xia Nong; Ying-Ying Ge; Li-Na Lin; Feng Li; Xiao-Xun Xie; Bin Luo
Journal:  Curr Med Sci       Date:  2022-06-08

4.  Effects of whole-life exposure to low-dose cadmium with post-weaning high-fat diet on offspring testes in a male mouse model.

Authors:  Lijuan Xiong; Bin Zhou; Jamie L Young; Jianxiang Xu; Kupper Wintergerst; Lu Cai
Journal:  Chem Biol Interact       Date:  2022-01-05       Impact factor: 5.192

Review 5.  The JAK/STAT signaling pathway: from bench to clinic.

Authors:  Xiaoyi Hu; Jing Li; Maorong Fu; Xia Zhao; Wei Wang
Journal:  Signal Transduct Target Ther       Date:  2021-11-26

Review 6.  The Dysregulation of Inflammatory Pathways Triggered by Copper Exposure.

Authors:  Huidan Deng; Song Zhu; Huiru Yang; Hengmin Cui; Hongrui Guo; Junliang Deng; Zhihua Ren; Yi Geng; Ping Ouyang; Zhiwen Xu; Youtian Deng; Yanqiu Zhu
Journal:  Biol Trace Elem Res       Date:  2022-03-21       Impact factor: 3.738

7.  MicroRNA-363-3p promote the development of acute myeloid leukemia with RUNX1 mutation by targeting SPRYD4 and FNDC3B.

Authors:  Yimin Chen; Shuyi Chen; Jielun Lu; Danyun Yuan; Lang He; Pengfei Qin; Huo Tan; Lihua Xu
Journal:  Medicine (Baltimore)       Date:  2021-05-07       Impact factor: 1.889

Review 8.  Evaluation of the target-specific therapeutic potential of herbal compounds for the treatment of cancer.

Authors:  Shobha Upreti; Satish Chandra Pandey; Ila Bisht; Mukesh Samant
Journal:  Mol Divers       Date:  2021-07-08       Impact factor: 2.943

9.  Blocking the JAK2/STAT3 and ERK pathways suppresses the proliferation of gastrointestinal cancers by inducing apoptosis.

Authors:  Xi Wang; Chunyan Dai; Yifei Yin; Lin Wu; Weiyang Jin; Yufei Fu; Zhe Chen; Ke Hao; Bin Lu
Journal:  J Zhejiang Univ Sci B       Date:  2021-06-15       Impact factor: 3.066

10.  The Effect of Janus Kinase Inhibitors and Phosphodiesterase-4 Inhibitors on Skin and Plasma Cytokine Levels in Patients with Psoriasis.

Authors:  O G Artamonova; A E Karamova; A A Nikonorov; D A Verbenko; E L Vasileva; A A Kubanov
Journal:  Bull Exp Biol Med       Date:  2021-06-26       Impact factor: 0.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.